HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


HAE: Haemonetics Corp - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
HAEMONETICS CORP (NYSE)
HAE 53.54 -1.22 (-2.23%) Vol.  323,095 16.00 CST

Nov 18, 2009 Trading Review for Cerus Corp. Issued by Beacon Equity
Nov 04, 2009 Haemonetics Reports Strong Results
Nov 02, 2009 Haemonetics Reaffirms
Nov 02, 2009 Haemonetics Reports Double Digit Growth in Earnings for Second Quarter Fiscal 2010
Nov 02, 2009 Conference Calls Today: 10-10:30 A.M. EDT
Oct 26, 2009 PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, October 26, 2009: BT, DEO, HAE, T, ATI and SVR
Oct 26, 2009 Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
Oct 16, 2009 Haemonetics Sets Date for Second Quarter Fiscal Year 2010 Earnings Release: November 2, 2009
Sep 19, 2009 Haemonetics Inks Software Deal
Sep 16, 2009 Haemonetics Signs Comprehensive Agreement with Blood Centers of America
Sep 14, 2009 Haemacure Reports on Current Activities and Third Quarter 2009 Financial Results
Sep 12, 2009 Haemonetics Down 4.1% Since SmarTrend's Sell Recommendation
Sep 08, 2009 Haemacure announces its presentation at the Rodman Renshaw 11th Annual Healthcare Conference
Sep 08, 2009 Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit
Aug 20, 2009 BayStreet.ca Research Alert: Haemacure Corp.
 
ZACKS COMMENTARY FOR HAE
Nov 16, 2009 Zacks Equity Research: Report for HAE
Nov 13, 2009 Zacks Blog: CFN Enters Agreement with Masimo
Nov 09, 2009 Zacks Blog: Masimo Beats Zacks Estimate
Nov 03, 2009 Zacks Blog: Haemonetics Reports Strong Results
Nov 02, 2009 Closing Market Commentary: Investors Saw a Resurgence of Volatility and Modest Gains
Oct 19, 2009 Zacks Blog: Haemonetics Enters Oversold Territory
Oct 16, 2009 Industry Outlook: Medical Devices
Oct 16, 2009 Zacks Analyst Interviews: Medical Devices
Oct 15, 2009 Zacks Blog: Medical Devices
Oct 13, 2009 Zacks Elite Stock of the Day: Haemonetics Corp.
Sep 18, 2009 Zacks Blog: Haemonetics Inks Software Deal
Sep 09, 2009 Zacks Blog: Haemonetics Acquires SEBRA

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research